These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2873722

  • 1. The pharmacological profile of a specific, safe, effective and non-sedative anti-allergic, astemizole.
    Niemegeers CJ, Awouters F, Janssen PA.
    Agents Actions; 1986 Apr; 18(1-2):141-4. PubMed ID: 2873722
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacology of astemizole (Hismanal) a non-sedating H1 antihistaminic].
    Niemegeers CJ.
    Z Hautkr; 1985 Apr; 60 Suppl 1():14-22. PubMed ID: 2581383
    [Abstract] [Full Text] [Related]

  • 3. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound.
    Van Wauwe J, Awouters F, Neimegeers CJ, Janssens F, Van Nueten JM, Janssen PA.
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):39-51. PubMed ID: 6114717
    [Abstract] [Full Text] [Related]

  • 4. Levocabastine: pharmacological profile of a highly effective inhibitor of allergic reactions.
    Awouters F, Niemegeers CJ, Jansen T, Megens AA, Janssen PA.
    Agents Actions; 1992 Jan; 35(1-2):12-8. PubMed ID: 1354927
    [Abstract] [Full Text] [Related]

  • 5. Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy.
    Richards DM, Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1984 Jul; 28(1):38-61. PubMed ID: 6204835
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B, Dordal A, Fort M, Galicia J, Farré AJ.
    Methods Find Exp Clin Pharmacol; 1996 Jul; 18(6):397-406. PubMed ID: 8892269
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacology of the specific histamine H1-antagonist astemizole.
    Awouters FH, Niemegeers CJ, Janssen PA.
    Arzneimittelforschung; 1983 Jul; 33(3):381-8. PubMed ID: 6135428
    [No Abstract] [Full Text] [Related]

  • 10. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T, Saito T, Tajima S, Shimohara K, Ito K.
    Arzneimittelforschung; 1984 Jul; 34(7):805-10. PubMed ID: 6208915
    [Abstract] [Full Text] [Related]

  • 11. [General review of a non-sedative antihistaminic, astemizole (Hismanal), a H1 receptor antagonist].
    Molkhou P.
    Allerg Immunol (Paris); 1988 May; 20(5):197-201. PubMed ID: 2900641
    [Abstract] [Full Text] [Related]

  • 12. The development of a new antihistamine: astemizole.
    Ray JA.
    N Engl Reg Allergy Proc; 1985 May; 6(1):71-7. PubMed ID: 2888010
    [Abstract] [Full Text] [Related]

  • 13. Effects of chlorpheniramine, pyrilamine and astemizole on intracranial self-stimulation in rats.
    Wauquier A, Niemegeers CJ.
    Eur J Pharmacol; 1981 Jun 19; 72(2-3):245-8. PubMed ID: 6113975
    [Abstract] [Full Text] [Related]

  • 14. Potential of interaction between the H1-antagonist astemizole and other drugs.
    Rombaut N, Heykants J, Vanden Bussche G.
    Ann Allergy; 1986 Nov 19; 57(5):321-4. PubMed ID: 2877601
    [Abstract] [Full Text] [Related]

  • 15. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May 19; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 16. Astemizole: a long-acting, nonsedating antihistamine.
    Krstenansky PM, Cluxton RJ.
    Drug Intell Clin Pharm; 1987 Dec 19; 21(12):947-53. PubMed ID: 2892659
    [Abstract] [Full Text] [Related]

  • 17. [A new H1-blocking antihistamine. Critical review of pharmacological and clinical studies].
    Emmi L, Rossi O.
    Minerva Med; 1988 Mar 19; 79(3):219-27. PubMed ID: 2896316
    [Abstract] [Full Text] [Related]

  • 18. [Astemizole: its pharmacokinetics and pharmacologic properties].
    Levron JC, Gillardin JM, Sabbah A.
    Allerg Immunol (Paris); 1990 Jun 19; 22(6):233-41. PubMed ID: 1974137
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of allergic reactions by a new antiallergic drug, LC-6 (trans-2,3b,4,5,7,8b,9,10-octahydronaphthol[1,2-c:5,6-c'] dipyrazole). I. Inhibition of the rat reaginic passive cutaneous anaphylaxis.
    Hurtado I, Márquez VE, Vítolo MJ.
    Int Arch Allergy Appl Immunol; 1978 Jun 19; 57(6):507-13. PubMed ID: 28295
    [Abstract] [Full Text] [Related]

  • 20. Astemizole and other H1-antihistaminic drug treatment of asthma.
    Holgate ST, Emanuel MB, Howarth PH.
    J Allergy Clin Immunol; 1985 Aug 19; 76(2 Pt 2):375-80. PubMed ID: 2862178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.